Update on Therapeutic Interventions for the Management of Achalasia.

Update on Therapeutic Interventions for the Management of Achalasia.

J Gastroenterol Hepatol. 2016 Apr 6;

Authors: Gunasingam N, Perczuk A, Talbot M, Kaffes A, Saxena P

Abstract
Achalasia is a primary oesophageal motility disorder. It is the absence of peristalsis in the oesophageal body and inability of the lower oesophageal sphincter to relax that characterises this rare condition. It's features typically include dysphagia, regurgitation, chest pain and weight loss. The ultimate goal in treating achalasia is to relieve the patient's symptoms, improve oesophageal emptying and prevent further dilatation of the oesophagus. Current treatment modalities targeted at achalasia include pharmacological therapy, endoscopic therapy and surgery. This review focuses on the current therapeutic options and explores the role of per oral endoscopic myotomy (POEM) in the management armamentarium.

PMID: 27060999 [PubMed - as supplied by publisher]

from #ENT via xlomafota13 on Inoreader http://ift.tt/1S71nHU
via IFTTT